Research / CCSI / Fundamental state Inspectable configuration
State dimensions Filing 0001866633-23-000017 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
864.47% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
7.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
2.89% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
83.20% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
35.58% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.53% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
5.18% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 21 states Self-history eligible
Dec 31, 2021 0/7 normalized Level 3 Mar 31, 2022 0/7 normalized Level 3 Jun 30, 2022 0/7 normalized Level 3 Sep 30, 2022 0/8 normalized Level 3 Sep 30, 2022 0/7 normalized Amended as filed Dec 31, 2022 0/8 normalized Level 3 Mar 31, 2023 0/8 normalized Level 3 Jun 30, 2023 0/8 normalized Level 3 Sep 30, 2023 3/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 827.20%
Current 864.47%
Delta 37.27% Capex Intensity Increased
Previous 7.63%
Current 7.97%
Delta 0.34% Growth Increased
Previous -47.33%
Current 2.89%
Delta 50.22% Margin Decreased
Previous 83.92%
Current 83.20%
Delta -0.72% Profitability Decreased
Previous 36.52%
Current 35.58%
Delta -0.94% R And D Intensity Increased
Previous 3.37%
Current 3.53%
Delta 0.15% Sbc Intensity Increased
Previous 4.81%
Current 5.18%
Delta 0.37% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.